These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3181610)

  • 1. Proposal for a function of the Leishmania donovani lipophosphoglycan.
    Turco SJ
    Biochem Soc Trans; 1988 Jun; 16(3):259-61. PubMed ID: 3181610
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions.
    Mahoney AB; Sacks DL; Saraiva E; Modi G; Turco SJ
    Biochemistry; 1999 Aug; 38(31):9813-23. PubMed ID: 10433687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes.
    McNeely TB; Turco SJ
    J Immunol; 1990 Apr; 144(7):2745-50. PubMed ID: 2319134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania.
    Lodge R; Descoteaux A
    Clin Immunol; 2005 Mar; 114(3):256-65. PubMed ID: 15721836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania.
    McNeely TB; Rosen G; Londner MV; Turco SJ
    Biochem J; 1989 Apr; 259(2):601-4. PubMed ID: 2524191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The leishmanial lipophosphoglycan: a multifunctional molecule.
    Turco SJ
    Exp Parasitol; 1990 Feb; 70(2):241-5. PubMed ID: 2404784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan.
    Sacks DL; Pimenta PF; McConville MJ; Schneider P; Turco SJ
    J Exp Med; 1995 Feb; 181(2):685-97. PubMed ID: 7836922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan.
    Orlandi PA; Turco SJ
    J Biol Chem; 1987 Jul; 262(21):10384-91. PubMed ID: 3611065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan.
    Desjardins M; Descoteaux A
    J Exp Med; 1997 Jun; 185(12):2061-8. PubMed ID: 9182677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein initiates transformation of Leishmania donovani and L. mexicana through binding to lipophosphoglycan.
    Mbuchi M; Bates PA; Ilg T; Coe JE; Raynes JG
    Mol Biochem Parasitol; 2006 Apr; 146(2):259-64. PubMed ID: 16417933
    [No Abstract]   [Full Text] [Related]  

  • 11. Leishmania donovani requires functional Cdc42 and Rac1 to prevent phagosomal maturation.
    Lerm M; Holm A; Seiron A; Särndahl E; Magnusson KE; Rasmusson B
    Infect Immun; 2006 May; 74(5):2613-8. PubMed ID: 16622197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies.
    McNeely TB; Tolson DL; Pearson TW; Turco SJ
    Glycobiology; 1990 Sep; 1(1):63-9. PubMed ID: 2136382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan.
    McNeely TB; Turco SJ
    Biochem Biophys Res Commun; 1987 Oct; 148(2):653-7. PubMed ID: 3689364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the phosphosaccharide-inositol core of the Leishmania donovani lipophosphoglycan.
    Turco SJ; Orlandi PA; Homans SW; Ferguson MA; Dwek RA; Rademacher TW
    J Biol Chem; 1989 Apr; 264(12):6711-5. PubMed ID: 2708338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface lipophosphoglycan of Leishmania donovani.
    King DL; Chang YD; Turco SJ
    Mol Biochem Parasitol; 1987 May; 24(1):47-53. PubMed ID: 3614272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced expression of lipophosphoglycan (LPG) and kinetoplastid membrane protein (KMP)-11 in Leishmania donovani promastigotes in axenic culture.
    Mukhopadhyay S; Sen P; Majumder HK; Roy S
    J Parasitol; 1998 Jun; 84(3):644-7. PubMed ID: 9645879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase.
    Balaraman S; Singh VK; Tewary P; Madhubala R
    Mol Biochem Parasitol; 2005 Jan; 139(1):117-27. PubMed ID: 15610826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania donovani exploits host deubiquitinating enzyme A20, a negative regulator of TLR signaling, to subvert host immune response.
    Srivastav S; Kar S; Chande AG; Mukhopadhyaya R; Das PK
    J Immunol; 2012 Jul; 189(2):924-34. PubMed ID: 22685311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophosphoglycan antigen shedding by Leishmania donovani.
    Kaneshiro ES; Wyder MA
    J Eukaryot Microbiol; 1993; 40(3):336-40. PubMed ID: 8508171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of inositol lipids from Leishmania donovani promastigotes: identification of an inositol sphingophospholipid.
    Kaneshiro ES; Jayasimhulu K; Lester RL
    J Lipid Res; 1986 Dec; 27(12):1294-303. PubMed ID: 3559392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.